Dates: TBS, 2021
Startup companies are often Innovation leaders in Life Science. Your passion, agility, creativeness and drive is often giving you the edge over larger, established companies.
But as your development advances, and studies become bigger and more complex, more defined processes, procedures and standards that ensure quality, consistency and economy of scale may be required. And though your Data is your biggest asset, keeping on top and in control of it, can soon become a challenge.
Join our virtual panel discussion to explore how can you stay on top & in control of your data as you advance from pre-clinical – to clinical development and onwards.
|Steven Porter, Senior Vice President Global Clinical Development at Arkbiosciences
|Isabel Coudert, Senior Director Clinical Operations, ADC Therapeutics
|Ahmed El Rhali, CEO datametrix|
|Henk Johnan Streefkerk MD, consultant CMO (OMEICOS; CellProthera)